Lysyl oxidases are enzymes which catalyze the final enzymatic modification of ε‐ amino groups of lysine residues of elastin, and lysine and hydroxylysine residues of collagens, to form peptidyl‐aldehydes required for biosynthetic cross‐linking and extracellular matrix maturation and function. This family includes lysyl oxidase (LOX) and lysyl oxidase‐like 1 – 4 (LOXL1 – LOXL4). CCN2 contributes to fibrosis development in gingival overgrowth caused by the anti‐seizure drug phenytoin, though the mechanism CCN2 is unclear. Here we investigate the hypothesis that CCN2 could up‐regulate LOXL2 to promote gingival fibroblast insoluble collagen deposition.CCN2 up‐regulated LOXL2 protein levels in primary human gingival fibroblast cultures. shRNA‐mediated knockdown of LOXL2 blocked collagen accumulation in CCN2‐treated and non‐treated primary human gingival fibroblast cultures determined by Sirius Red staining. DNA in cell layers was also strongly diminished in cell layers. Cell proliferation was decreased in LOXL2 shRNA transduced cells, while apoptosis was not affected. Active LOXL2 enzyme addition promoted both increased proliferation and cell layer collagen accumulation.LOXL2 has two important functions in the development of gingival fibrosis: its known role in promoting collagen maturation, and the new role of promoting cell proliferation. The mechanism of promotion of proliferation of gingival fibroblasts by LOXL2 is under investigation.Supported by R01 DE11004.